Beaton Management Company’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$320K Hold
2,022
0.13% 126
2026
Q1
$258K Hold
2,022
0.11% 129
2025
Q4
$247K Sell
2,022
-28
-1% -$3.21K 0.11% 132
2025
Q3
$205K Buy
+2,050
New +$185K 0.09% 142
2024
Q4
Sell
-2,150
Closed -$212K 136
2024
Q3
$212K Buy
+2,150
New +$211K 0.11% 133
2022
Q1
Sell
-2,190
Closed -$245K 147
2021
Q4
$245K Hold
2,190
0.15% 129
2021
Q3
$275K Hold
2,190
0.18% 117
2021
Q2
$297K Hold
2,190
0.19% 112
2021
Q1
$297K Hold
2,190
0.21% 106
2020
Q4
$308K Sell
2,190
-60
-3% -$7.68K 0.23% 100
2020
Q3
$251K Hold
2,250
0.21% 102
2020
Q2
$252K Buy
+2,250
New +$222K 0.22% 97
2020
Q1
Sell
-2,250
Closed -$214K 121
2019
Q4
$214K Buy
+2,250
New +$195K 0.17% 118
2019
Q3
Sell
-2,300
Closed -$202K 122
2019
Q2
$202K Sell
2,300
-100
-4% -$8.53K 0.17% 115
2019
Q1
$217K Buy
+2,400
New +$204K 0.19% 113
2018
Q4
Sell
-2,350
Closed -$225K 120
2018
Q3
$225K Buy
2,350
+50
+2% +$4.85K 0.19% 113
2018
Q2
$219K Buy
+2,300
New +$211K 0.2% 113

Other funds holding XBI

Beaton Management Company's XBI Position: Q2 2026 in Review

Beaton Management Company held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q2 2026 at 2,022 shares worth $320K. The position accounts for 0.13% of the portfolio, ranked #126.

Beaton Management Company first reported a position in XBI in Q2 2018 and has held it in 17 quarters since. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • Beaton Management Company held 2,022 shares of State Street SPDR S&P Biotech ETF worth $320K as of Q2 2026.
  • Beaton Management Company left its State Street SPDR S&P Biotech ETF share count unchanged in Q2 2026.
  • State Street SPDR S&P Biotech ETF made up 0.13% of Beaton Management Company's portfolio in Q2 2026, its #126 holding.
  • Beaton Management Company first reported a position in State Street SPDR S&P Biotech ETF in Q2 2018 and has held it in 17 quarters since.
  • 933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Beaton Management Company's 13F filing for Q2 2026, filed 7 Aug 2026.